Maharaj Institute of Immune Regenerative Medicine

Recent papers from Maharaj Institute of Immune Regenerative Medicine

1. Interleukin-2 and Tretinoin for Myeloproliferative Neoplasms and to Target Type 1 Calreticulin-Driven Neoplasms: Advancements in Immune Regenerative MedicineInternational Journal of Molecular Sciences · 2026
2. Reg-GPT ™ : A Conversational AI Model for Enhanced Decision-Making in Regenerative Medicine2025
3. Low-Toxicity Natural Killer Cell-Based Immunotherapy for NRAS-Driven Mucosal Melanoma: Advances in Immune Regenerative MedicineCritical Reviews in Immunology · 2025
4. Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral SclerosisCritical Reviews in Immunology · 2023
5. The Potential Role of Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis (ALS); A Longitudinal Case Study Comparing Patients with Genetically Identical Healthy TwinCritical Reviews in Immunology · 2023
6. Personalized Precision Immunotherapy for Amyotrophic Lateral Sclerosis (ALS)Critical Reviews in Immunology · 2023
7. The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)Cells · 2022
8. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationBiology of Blood and Marrow Transplantation · 2021
9. Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain SyndromeJournal of Personalized Medicine · 2021
10. Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic LeukemiaCells · 2020
11. The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) EraBiology of Blood and Marrow Transplantation · 2020
12. Molecular Remission using Low-Dose Immunotherapy for Relapsed Refractory Philadelphia Chromosome-Positive Precursor B-cell Acute Lymphoblastic Leukemia Post-Allogeneic Stem Cell TransplantFuture Science OA · 2019
13. Young donor white blood cell immunotherapy induces extensive tumor necrosis in advanced-stage solid tumorsHeliyon · 2017
14. Allogeneic Hematopoietic Cell Transplant for Prolymphocytic LeukemiaBiology of Blood and Marrow Transplantation · 2009
15. Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell LymphomaBiology of Blood and Marrow Transplantation · 2009
16. Comparison of Twin and Autologous Transplants for Multiple MyelomaBiology of Blood and Marrow Transplantation · 2008
17. Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative ConditioningBiology of Blood and Marrow Transplantation · 2008